Delivery Order SPE2DB22D1103-SPE2DB25FTEE7
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,399.72 firm fixed price delivery order contract is for the supply of 4,567,582,710 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,283.49 firm fixed-price delivery order is for the supply of 4,565,622,917 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of August 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.95 firm-fixed-price delivery order is for the supply of 4,566,340,680 units of the prescription drug Vyvanse 40 mg capsules. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,968.56 firm-fixed-price delivery order is for the supply of 4,567,025,816 units of the medication Vyvanse 60 mg capsules. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,849.36 firm-fixed-price delivery order is for the provision of 4,563,139,143 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen is the prime contractor, with no mentioned subcontractors. This award is part of a larger $999,999,999 Indefinite...
This federal contract award, valued at $1,187.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyvanse 40 mg capsules and has a completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,718.32 firm fixed-price delivery order is for the supply of 4,566,518,420 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,218,559 units of Vyvanse 40 mg capsules. The $3,376.76 firm-fixed-price delivery order has a completion date of July 23, 2024 and is not set aside for any specific business category. AmerisourceBergen, through its corporate office division, is the prime contractor and will be responsible for supplying these prescription...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,016.48 firm fixed-price delivery order is for the supply of 100 units of the prescription medication Vyvanse (40 mg capsules). The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,296.22 firm fixed-price delivery order is for the supply of 4,566,498,336 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...